Article info
PostScript
Letter
PPIs and anti-TNF in patients with IBD: a forbidden combination?
- Correspondence to Dr Judith Wellens, Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven Gasthuisberg Campus, Leuven, Flanders, Belgium; Judith.wellens{at}kuleuven.be
Citation
PPIs and anti-TNF in patients with IBD: a forbidden combination?
Publication history
- Received January 5, 2021
- Revised January 20, 2021
- Accepted January 22, 2021
- First published January 29, 2021.
Online issue publication
January 08, 2022
Article Versions
- Previous version (8 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.